The four-plates test-retest paradigm to discriminate anxiolytic effects

Psychopharmacology

Volumn 180, Issue 1, 2005, Pages 73-83

  Ripoll, Nadège ^a   Dhonnchadha, Bríd Áine Nic ^a   Sébille, Véronique ^a   Bourin, Michel ^a   Hascoët, Martine ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Antidepressant; Anxiety; Benzodiazepine; Four plates test; Test experience

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPRAZOLAM; ANXIOLYTIC AGENT; ATROPINE; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; DIAZEPAM; FLUMAZENIL; MUSCARINIC RECEPTOR BLOCKING AGENT; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DISCRIMINATION LEARNING; DISCRIMINATIVE STIMULUS; MALE; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANQUILIZING ACTIVITY;

ADRENERGIC UPTAKE INHIBITORS; AMPHETAMINES; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; ATROPINE; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BENZODIAZEPINES; CHOLINERGIC AGENTS; CYCLOHEXANOLS; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; PAROXETINE; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, GABA-A; SEROTONIN UPTAKE INHIBITORS;

EID: 21244484254     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-2130-1     Document Type: Article

References (61)

1. 2 receptor regulation of extracellular GABA levels in the prefrontal cortex. Neuropsychopharmacology 20:92-96
2. Andrews N, File SE (1993) Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety. Eur J Pharmacol 235:109-112
3. Aron C, Simon P, Larousse C, Boissier JM (1971) Evaluation of a rapid technique detecting minor tranquilizers. Neuropharmacology 10:459-469
4. Bertoglio LJ, Carobrez AP (2002a) Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze. Pharmacol Biochem Behav 72:449-455
5. Bertoglio LJ, Carobrez AP (2002b) Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze. Pharmacol Biochem Behav 73:963-969
6. Bertoglio LJ, Carobrez AP (2004) Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2. Behav Pharmacol 15:45-54
7. Biggio G, Concas A, Corda MG, Giorgi O, Sanna E, Serra M (1990) GABAergic and dopaminergic transmission in the rat cerebral cortex: effect of stress, anxiolytic and anxiogenic drugs. Pharmacol Ther 48:121-142
8. Boissier JR, Simon P, Aron C (1968) A new method for rapid screening of minor tranquillizers in mice. Eur J Pharmacol 4:145-151
9. Borsini F, Podhorna J, Marazziti D (2002) Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology (Berl) 163:121-141
10. Bortolozzi A, Amargos-Bosch M, Adell A, Diaz-Mataix L, Serrats J, Pons S, Artigas F (2003) In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs. Eur J Neurosci 18:1235-1246
11. Bourin M, Baker GB (1996) The future of antidepressants. Biomed Pharmacother 50:7-12
12. Bourin M, Hascoët M, Mansouri B, Colombel MC, Bradwejn J (1992) Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models. J Psychiatry Neurosci 17:72-77
13. Castellano C, Cabib S, Puglisi-Allegra S, Gasbarri A, Sulli A, Pacitti C, Introini-Collison IB, McGaugh JL (1999) Strain-dependent involvement of D1 and D2 dopamine receptors in muscarinic cholinergic influences on memory storage. Behav Brain Res 98:17-26
14. Cook MN, Crounse M, Flaherty L (2002) Anxiety in the elevated zero-maze is augmented in mice after repeated daily exposure. Behav Genet 32:113-118
15. Cruz-Morales SE, Santos NR, Brandao ML (2002) One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat. Pharmacol Biochem Behav 72:973-978
16. Dunham NW, Mya TS (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc 46:208-209
17. File SE (1990) One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology (Berl) 100:281-282
18. File SE (1993) The interplay of learning and anxiety in the elevated plus-maze. Behav Brain Res 58:199-202
19. File SE (2001) Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res 125:151-157
20. File SE, Zangrossi H Jr (1993) "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology (Berl) 110:240-244
21. File SE, Mabbutt PS, Hitchcott PK (1990) Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology (Berl) 102:98-101
22. File SE, Andrews N, Wu PY, Zharkovsky A, Zangrossi H Jr (1992) Modification of chlordiazepoxide's behavioural and neurochemical effects by handling and plus-maze experience. Eur J Pharmacol 218:9-14
23. Flood JF, Landry DW, Jarvik ME (1981) Cholinergic receptor interactions and their effects on long-term memory processing. Brain Res 215:177-185
24. Gaggi R, Dall'Olio R, Roncada P (1997) Effect of the selective 5-HT receptor agonists 8-OHDPAT and DOI on behavior and brain biogenic amines of rats. Gen Pharmacol 28:583-587
25. Gobert A, Millan MJ (1999) Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 38:315-317
26. Hascoët M, Bourin M, Couetoux du Tertre A (1997) Influence of prior experience on mice behavior using the four-plates test. Pharmacol Biochem Behav 58:1131-1138
27. Hascoët M, Bourin M, Colombel MC, Fiocco AJ, Baker GB (2000) Anxiolytic-like effects of antidepressants after acute administration in a four-plates test in mice. Pharmacol Biochem Behav 65:339-344
28. Holmes A, Rodgers RJ (1998) Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state? Pharmacol Biochem Behav 60:473-488
29. Holmes A, Rodgers RJ (1999) Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci Biobehav Rev 23:971-980
30. Holmes A, Rodgers RJ (2003) Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine. Eur J Pharmacol 459:221-230
31. Holmes A, Iles JP, Mayell SJ, Rodgers RJ (2001) Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test. Behav Brain Res 122:159-167
32. 2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release. Brain Res 907:151-155
33. Ichikawa J, Ishii H, Bonaccorso S, Fowler WL, O'Laughlin IA, Meltzer HY (2001) 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 76:1521-1531
34. Jacob JJ, Tremblay EC, Colombel MC (1974) Enhancement of nociceptive reactions by naloxone in mice and rats. Psychopharmacologia 37:217-223
35. Lamprea MR, Cardenas FP, Silveira R, Morato S, Walsh TJ (2000) Dissociation of memory and anxiety in a repeated elevated plus maze paradigm: forebrain cholinergic mechanisms. Behav Brain Res 117:97-105
36. Liao JF, Hung WY, Chen CF (2003) Anxiolytic-like effects of baicalein and baicalin in the Vogel conflict test in mice. Eur J Pharmacol 464:141-146
37. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92:180-185
38. McGregor IS, Dielenberg RA (1999) Differential anxiolytic efficacy of a benzodiazepine on first versus second exposure to a predatory odor in rats. Psychopharmacology (Berl) 147:174-181
39. Meneses A (2002) Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism? Cell Mol Neurobiol 22:675-688
40. Meneses A, Hong E (1999) 5-HT1A receptors modulate the consolidation of learning in normal and cognitively impaired rats. Neurobiol Learn Mem 71:207-218
41. 2 ligands on three mouse models of anxiety. Behav Brain Res 140:203-214
42. 2A receptor mode of action in the anxiolytic-like properties of DOI in mice. Behav Brain Res 147:175-184
43. 2 receptor subtypes in the mechanism of action of antidepressants in the mouse four plates test
44. Nutt DJ, Malizia AL (2001) New insights into the role of the GABA (A)-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry 179:390-396
45. Pan SY, Han YF (2000) Learning deficits induced by 4 belladonna alkaloids are preferentially attenuated by tacrine. Acta Pharmacol Sin 21:124-130
46. Pattij T, Groenink L, Oosting RS, van der Gugten J, Maes RA, Olivier B (2002) GABA(A)-benzodiazepine receptor complex sensitivity in 5-HT(1A) receptor knockout mice on a 129/Sv background. Eur J Pharmacol 447:67-74
47. Pehek EA, McFarlane HG, Maguschak K, Price B, Pluto CP (2001) M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Res 888:51-59
48. Pierce PA, Peroutka SJ (1989) Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex. Psychopharmacology 97:118-122
49. 2C receptors in CHO-K1 cells. Br J Pharmacol 128:13-20
50. 2 receptors produces retrograde amnesia in rats. Life Sci 74:481-488
51. Ripoll N, Hascoët M, Bourin M. The four-plate test: anxiolytic paradigm or analgesic one? submitted in Behav Brain Res
52. Rodgers RJ, Shepherd JK (1993) Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology (Berl) 113:237-242
53. Rodgers RJ, Lee C, Shepherd JK (1992) Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology (Berl) 106:102-110
54. Rodgers RJ, Johnson NJ, Cole JC, Dewar CV, Kidd GR, Kimpson PH (1996) Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade. Pharmacol Biochem Behav 54:41-50
55. Sanchez C, Hyttel J (1999) Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 19:467-489
56. Shimada T, Matsumoto K, Osanai M, Matsuda H, Terasawa K, Watanabe H (1995) The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs. Gen Pharmacol 26:205-210
57. Steenbergen HL, Heinsbroek RP, Van Hest A, Van de Poll NE (1990) Sex-dependent effects of inescapable shock administration on shuttlebox-escape performance and elevated plus-maze behavior. Physiol Behav 48:571-576
58. 2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 94:213-216
59. Vaswani M, Linda FK, Ramesh S (2003) Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuro-Psychopharmacol Biol Psychiatry 27:85-102
60. Williams GV, Rao SG, Goldman-Rakic PS (2002) The physiological role of 5-HT2A receptors in working memory. J Neurosci 22:2843-2854
61. Zangrossi H Jr, File SE (1992) Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor. Brain Res Bull 29:381-388